[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353920-105":59,"doc-detail-353920-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-tumor-microenvironment-as-a-key-regulator-of-radiotherapy-response","The tumor microenvironment as a key regulator of radiotherapy response","","Radiotherapy remains central to solid tumor care, yet treatment failure and resistance frequently emerge from changes beyond cancer cell DNA damage. The review explains how radiotherapy remodels the tumor microenvironment, driving vascular injury that deepens hypoxia, stromal activation that supports fibrosis and extracellular matrix remodeling, and immune reprogramming that can include both immunogenic cell death and formation of an immunosuppressive niche enriched with regulatory T cells and myeloid-derived suppressor cells. It synthesizes mechanisms linking these alterations to radiotherapy resistance and recurrence and outlines therapeutic strategies such as vascular normalization, hypoxia targeting, and combination with immune checkpoint blockade.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-tumor-microenvironment-as-a-key-regulator-of-radiotherapy-response/353920/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-tumor-microenvironment-as-a-key-regulator-of-radiotherapy-response/353920.png","ImageObject",300,407,{"name":92,"@type":93},"Jacob","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does the tumor microenvironment influence radiotherapy effectiveness?","Question",{"text":112,"@type":113},"The tumor microenvironment shapes therapeutic efficacy through interactions among stromal cells, vasculature, immune infiltrates, and extracellular matrix, which can support regression or promote resistance after irradiation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What radiotherapy-induced vascular changes contribute to resistance?",{"text":117,"@type":113},"Radiation can damage tumor vasculature, increasing hypoxia and acidosis and causing abnormal, leaky vessel remodeling that reduces long-term radiotherapy benefits and supports resistance.",{"name":119,"@type":110,"acceptedAnswer":120},"Which combination strategies are suggested to overcome microenvironment-mediated radioresistance?",{"text":121,"@type":113},"Promising approaches include vascular normalization, targeting hypoxia-inducible pathways, and combining radiotherapy with immunotherapies such as immune checkpoint blockade.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353920,1790146244,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962084931830,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","TYPE Mini Review  \nPUBLISHED 11 March 2026  \nDOI 10.3389/fimmu.2026.1776636  \nOPEN ACCESS  \nEDITED BY  \nYunfei Liu,  \nCentral South University, China  \nREVIEWED BY  \nYingzhao Wang,  \nNew York University, United States  \n*CORRESPONDENCE  \nNa Zhang  \n[Zhangna20231215@126.com](Zhangna20231215@126.com)  \nRECEIVED 28 December 2025  \nREVISED 22 February 2026  \nACCEPTED 24 February 2026  \nPUBLISHED 11 March 2026  \nCITATION  \nMa X and Zhang N (2026) The tumor microenvironment as a key regulator of radiotherapy response.  \nFront. Immunol. 17:1776636 .  \ndoi: 10.3389/fimmu.2026.1776636  \nCOPYRIGHT  \n© 2026 Ma and Zhang. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nThe tumor microenvironment as a key regulator of radiotherapy response  \nXinchi Ma and Na Zhang*  \nDepartment of Radiation Oncology, Liaoning Cancer Hospital & Institute, Shenyang, China  \nRadiotherapy (RT) remains a cornerstone of cancer treatment, yet its efﬁcacy is often limited by tumor recurrence and resistance. Emerging evidence underscores the pivotal role of the tumor microenvironment (TME) in this process. RT-induced vascular damage exacerbates hypoxia, a key driver of resistance, while activation of cancer-associated ﬁbroblasts promotes ﬁbrosis and extracellular matrix remodeling that shield tumor cells. Furthermore, RT elicits a complex immune response, capable of both immunogenic cell death and fostering an immunosuppressive milieu enriched with regulatory T cells and myeloid-derived suppressor cells. We discuss the mechanisms through which these TME alterations, hypoxia, ﬁbrotic signaling, and immune evasion, collectively contribute to RT resistance and recurrence. In this review, we summarize current knowledge on how RT remodels the TME, focusing on its dualistic impact on vascular integrity, stromal activation, and immune regulation. Finally, we outline the promising therapeutic strategies in overcoming TMEmediated resistance, including vascular normalization, targeting hypoxiainducible factors, and combining RT with immunotherapies such as immune checkpoint blockade. Overall, a deeper understanding of TME dynamics post-RT is crucial for developing novel combination therapies to improve clinical outcomes.  \nKEYWORDS  \ncancer, cancer-associated ﬁbroblasts, combination therapy, hypoxia, immune suppression, radiotherapy resistance, VEGF  \n1 Introduction  \nRadiotherapy (RT) remains a mainstay in the treatment of solid tumors, contributing to curative intent in over 50% of cancer patients (1) . Historically, research in radiation oncology has centered on tumor-intrinsic responses to DNA damage, including cell cycle arrest, apoptosis, and mitotic catastrophe (2) . However, accumulating evidence over the past two decades has revealed that the tumor microenvironment (TME)—comprising stromal cells, vasculature, immune inﬁltrates, and extracellular matrix (ECM)—plays an equally critical role in shaping therapeutic efﬁcacy (3, 4) . Ionizing radiation not only damages cancer cells but also profoundly reshapes the TME, triggering complex and often paradoxical responses that can either support tumor regression or promote therapeutic resistance (5, 6) . TME components such as cancer-associated ﬁbroblasts (CAFs), tumor vasculature, and inﬁltrating immune cells dynamically interact with irradiated tumor cells through signaling networks involving hypoxia-inducible factors (HIF-1a), angiogenic mediators (VEGF), and immunoregulatory cytokines (TGF-b, IL-6) (7–9) . These interactions modulate  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \ninﬂammation, ﬁbrosis, immun","cbCaiivD4PKm16h4","https://ap.wps.com/l/cbCaiivD4PKm16h4","pdf",1381954,"English","# Introduction\n# Effects of radiotherapy on the tumor microenvironment\n## Effects of radiotherapy on the vasculature system","[{\"question\":\"How does the tumor microenvironment influence radiotherapy effectiveness?\",\"answer\":\"The tumor microenvironment shapes therapeutic efficacy through interactions among stromal cells, vasculature, immune infiltrates, and extracellular matrix, which can support regression or promote resistance after irradiation.\"},{\"question\":\"What radiotherapy-induced vascular changes contribute to resistance?\",\"answer\":\"Radiation can damage tumor vasculature, increasing hypoxia and acidosis and causing abnormal, leaky vessel remodeling that reduces long-term radiotherapy benefits and supports resistance.\"},{\"question\":\"Which combination strategies are suggested to overcome microenvironment-mediated radioresistance?\",\"answer\":\"Promising approaches include vascular normalization, targeting hypoxia-inducible pathways, and combining radiotherapy with immunotherapies such as immune checkpoint blockade.\"}]","The tumor microenvironment as a key regulator of radiotherapy response | PDF",1790107910,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c29ebcd737f851a594534dab652cd621.webp",983,1389,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f0c40f512e7c365f4559e5cf3dd7f4c.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b044345581e7ad87fb6f36230897983c.webp",981,1386,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d7117bafd86b0b0275ca8e81c42d1236.webp",980,1385]